| Lung Cancer |
| No. |
|
Title |
|
Author |
| 521 |
|
Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University
Ann Oncol. 2006 Jan;17(1):97-103 [read] |
|
Kurup A, Lin CW, Murry DJ, Dobrolecki L, Estes D, Yiannoutsos CT, Mariano L, Sidor C, Hickey R, Hanna N |
| 328 |
|
Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome
Clinical Chemistry, 51:1 (2005) 56-64
[read] |
|
Xixiong Kang, Yang Xu, Xiaoyi Wu |
| 259 |
|
Myristoylation of the Fus1 Protein Is Required for Tumor Suppression in Human Lung Cancer Cells
Cancer Research, 64, 2969-2976, (2004
[read] |
|
Uno, F., Sasaki, J., Nishizaki, M., Carboni, G., Xu, K., Atk |
| 176 |
|
Immuno affinity purification combined with mass spectrometry detection for the monitoring of VEGF isoforms in patient tumor tissue
Journal of Separation Science, 26, 619-623, (2003)
[read] |
|
Landuyt, B., Jansen, J., Wildiers, H., Goethals, L., De BoecLanduyt, B., Jansen, J., Wildiers, H., Goethals, L., De Boec |
| 174 |
|
Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry
Lung Cancer, 40, 267-279, (2003)
[read] |
|
Zhukov, T.A., Johanson, R.A., Cantor, A.B., Clark, R.A |
|
|
